The future of high-throughput screening

High-throughput screening (HTS) is a method for drug discovery that allows automated testing of large numbers of chemical and biological compounds for a specific biological target.

Strategies Undertaken By Pharma Industry To Cut Pollution

Ten of the largest pharma companies in the world have pledged to boosting the energy efficiency of their processes as part of an initiative called Energize.

Issues With Accelerated Approval Remain A Problem For FDA

Delays in the sponsors delivering living proof from post-approval trials, and clearance of critical treatments on scant clinical evidence are critical issues.

Lilly, AZ, AbbVie, J&J May Be Hit By Medicare Pricing Bill

Biopharma aficionados are anxiously awaiting the Senates passage of a drug pricing bill before it leaves for recess at the end of the first week of August.

Patient Groups Rejoice As Pharma Dismisses Drug Pricing Law

Biopharma firms will hack law change by narrowing product choices, allowing drugs to be procured from many sources, and dodging pricing rules, say SVB analysts.

Pharmacopoeias To Aid Vaccine Creation And Research Further

The US Pharmacopeia and the European Pharmacopoeia have both declared new proposals to aid in the promotion of vaccine development, manufacture, and quality.

New Zealand Accelerates Alzheimer's Treatment Development

Identification of a particular brain protein that may be advantageous in treating Alzheimers is incredibly exciting news for patients and the health spectrum.